Device Trial Radar · NCT04463121
Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)
Last checked: Nov 19, 2026Latest source record: Jun 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
22
Actual
Start
Aug 7, 2020
Primary completion
Feb 16, 2023
Study completion Feb 16, 2023
Sponsor
- Lead sponsor
- BackBeat Medical IncNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- CD Leycom
- First posted
- Jul 9, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This investigation will evaluate the effect of RV pacing lead position on cardiac function and the modulation of the autonomic nervous system with Cardiac Neuromodulation Therapy (CNT) pacing signals. The study will be performed acutely prior to a pacemaker implant.
Conditions
- Bradycardia
- Hypertension, Systolic
Interventions
Moderato IPG's CNT pacing signalsDevice
Assesment of cardiac function and sympatheric activity will be obtained simultaneously
CD Leycom Pressure/Volume Combination CathetersDevice
Simultaneous recording of the Pressure, Volume measurements and ECG signals will be done for constant monitoring of intra-ventricular pressure and volume.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effects of the Moderato CNT pacing signals on cardiac functionTime frame: approximately one hour
- Effects of CNT pacing signals on blood pressureTime frame: aproximately onr hour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Na Homolce Hospital
Prague, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.